Penwest Pharmaceuticals have initiated a Phase IIa Clinical Trial for A0001 due to commence in December. Screening of prospective patients is underway. The study will be conducted at the Children’s Hospital of Philadelphia. The Phase IIa Clinical Trial is a double-blind, randomised, placebo-controlled trial that includes high and low doses of A0001 and a placebo. […]